Jiang-hui T. Wang is an ophthalmologist based in East Melbourne, VIC. The practice is at Level 7, 32 Gisborne Street, East Melbourne, VIC 3002. If you’re dealing with changes to your vision, eye pain, or trouble seeing fine details, Dr Wang helps people understand what’s going on and what can be done next.
As an eye specialist, Dr Wang looks after conditions that affect the retina and the macula, which are the parts of the eye that help with sharp, detailed sight. This can include diabetic retinopathy and diabetic macular oedema, where diabetes can slowly affect the back of the eye over time. It also includes age-related macular degeneration (often called ARMD), which is a common cause of vision changes as we get older.
Dr Wang also treats retinal problems that are not linked to diabetes. At times, that can include inherited conditions such as Leber congenital amaurosis. In some cases, people may also have late-onset retinal degeneration. Another condition seen in practice is Bietti crystalline dystrophy (BCD), which can cause changes to the retina and can affect how well you see.
Eye care can feel a bit overwhelming, especially when the changes happen slowly. Dr Wang’s approach stays practical and grounded. Appointments usually focus on checking vision, looking at the back of the eye, and talking through results in plain language. From there, management plans may involve monitoring and treatment options, depending on the condition and how it’s tracking.
In many cases, ongoing follow-up matters. Some eye conditions can change over time, so regular reviews can help catch new problems early. That can make a real difference for long-term vision outcomes.
Education and experience details weren’t listed here, so the specific training background and years of practice can’t be confirmed from this page. If you’d like more detail, it’s best to contact the practice directly.
There isn’t any specific information listed here about research or clinical trials. Even so, ophthalmology care often involves staying up to date with new evidence and treatment options, especially for retinal conditions.
